Target species Cattle. Indications for use, specifying the target species For therapeutic treatment of bovine respiratory disease (BRD) associated with pyrexia due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni susceptible to florfenicol. Contraindications Do not use in adult bulls intended for breeding. Do not use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders, or when there is evidence of ulcerogenic gastrointestinal lesions. Do not use in case of hypersensitivity to the active substances or to any of the excipients. Special warnings for each target species None. Special precautions for use Special precautions for use in animals Whenever possible, the veterinary medicinal product should only be used based on susceptibility testing. Official, national and regional antimicrobial policies should be taken into account when the veterinary medicinal product is used. Avoid use in severely dehydrated, hypovolaemic or hypotensive animals, as there may be a potential risk of renal toxicity. In the absence of safety data it is not recommended to use the product in calves less than 4 weeks old. Special precautions to be taken by the person administering the veterinary medicinal product to animals The product is slightly irritant to the eye. Rinse any splashes from eyes immediately with plenty of water. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. People with known hypersensitivity to florfenicol, meloxicam or to any of the excipients should avoid contact with the veterinary medicinal product. Dose dependent maternotoxic and foetotoxic effects have been observed after oral administration of meloxicam to pregnant rats. Therefore, the veterinary medicinal product should not be administered by pregnant women. Adverse reactions (frequency and seriousness) Injection site reactions (mostly swelling, induration, heat and pain) were very commonly observed after subcutaneous administration of the product. These effects were transitory and usually resolved without any treatment within 5 to 15 days, but could persist up to 49 days. During injection of this product animals may exhibit signs of moderate pain, manifested as movement of the head or neck. Use during pregnancy, lactation or lay The safety of the veterinary medicinal product has not been established in breeding, pregnant and lactating animals. Use only according to the benefit-risk assessment by the responsible veterinarian. Fertility: Do not use in adult bulls intended for breeding (see Contraindications). Interaction with other medicinal products and other forms of interaction Do not administer concurrently with glucocorticoids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Vat Rate: 20%